Effect of Helicobacter pylori eradication on gastric ulcer recurrence. A 12 month follow-up study;Efecto de la erradicación de Helicobacter pylori sobre la recurrencia de la úlcera gástrica a lo largo de 12 meses

Medicina Clinica

Volumn 115, Issue 6, 2000, Pages 201-204

  Bermejo, Fernando ^a,c   Boixeda, Daniel ^a   Gisbert, Javier P ^b   Defarges, Víctor ^a   De Argila, Carlos Martín ^a   Sanz, Jesús M ^a   García Plaza, Antonio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c NONE   (Spain)

Author keywords

Eradication; Gastric ulcer; Helicobacter pylori; Recidive; Recurrence; Reinfection

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ANTIULCER AGENT; CLARITHROMYCIN; OMEPRAZOLE; PENICILLIN DERIVATIVE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; COMPARATIVE STUDY; DRUG COMBINATION; FEMALE; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RECURRENT DISEASE; STATISTICAL ANALYSIS; STOMACH ULCER; TIME;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CLARITHROMYCIN; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROSPECTIVE STUDIES; RECURRENCE; STOMACH ULCER; TIME FACTORS;

EID: 0041730671     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71509-0     Document Type: Article

References (38)

1. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-1252.
2. Van der Hulst RWM, Tylgast GNJ. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol 1996; 31 (Supl 220): 10-18.
3. Laine L, Hopkins RJ, Girardi LS Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A metaanalysis of rigorously designed trials. Gastroenterology 1998; 93: 1409-1415.
4. Gisbert JP, Boixeda D, Martin de Argila C, García Plaza A. Helicobacter pylori y úlcera duodenal: ¿relación causal o mera asociación? Rev Clin Esp 1997; 197: 693-702.
5. Gisbert JP, Boixeda D, Redondo C, Álvarez Baleriola I, Jimenez I, Pérez García et al. Prueba del aliento para el diagnóstico de infección por Helicobacter pylori: concordancia con los métodos histológicos y correlación con las lesiones anatomopatológicas de la mucosa gástrica. Rev Esp Enferm Dig 1996; 88: 259-264.
6. Martín de Argila C, Boixeda D, Cantón R, Mir N, De Rafael L, Gisbert JP et al. Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol 1996: 8: 1165-1168.
7. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
8. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV et al. Design and analysis of radomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
9. Hanscom DH, Buchman E. The follow-up period. Gastroerterology 1971; 61: 714-717.
10. Baume PE, Hunt JH, Piper DW. Glycopyrronium bromide in the treatment of chronic gastric ulcer. Gastroenterology 1972; 63: 399-406.
11. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ, Saeed ZA et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomised, controlled study. Ann Intern Med 1992; 116: 705-708.
12. Bayerdörffer E, Mannes GA, Höchter W. Antibacterial treatment of gastric ulcers. German gastric ulcer study. Ir J Med 1992; 61 (Supl 10): 30.
13. Karita M, Morshed MG, Ouchi K. Okita K. Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate. Am J Gastroenterol 1994; 89: 1032-1035.
14. Labenz J, Börsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994; 89: 1785-1788.
15. Sung JJY, Chung SCS, Ling TKW, Yung MY, Leung VKS, Ng EKW et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-142.
16. Seppälä K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH and the Finnish Gastric Ulcer Study Group. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Gut 1995; 36: 834-837.
17. Axon ATR, O'Morain CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RPH et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997; 314: 565-568.
18. Kim O, Oh JH, Lee CG, Lim C, Won KH, Choi WR et al. Effect of eradication of Helicobacter pylori on the benign gastric ulcer recurrence: a 24 month follow-up study. Korean J Intern Med 1999; 14: 9-14.
19. Penston JG, Wormsley KG. Efficacy and safety of long-term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989; 24: 1145-1148.
20. Miehlke S, Bayerdörffer E, Lehn N, Mannes GA, Hochter W, Weingart J et al. Recurrence of duodenal ulcers during five years of follow-up after cure of H. pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 975-978.
21. Bayerdörffer E, Mannes GA, Sommer A, Hochter W, Weingart J, Hatz R et al. Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scand J Gastroenterol 1993; 28 (Supl 196): 19-25.
22. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KJ, Marshall BJ et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow up. Lancet 1994; 343: 258-261.
23. Gisbert JP. Reinfección por Helicobacter pylori tras su erradicación ¿un temor infundado? Med Clin (Barc) 1998; 111: 380-384.
24. Deltenre M, Glupzcynski Y, De Prez C, Nyst JF, Burette A, Labbe M et al. The reliability of urease tests, histology, and culture in the diagnosis of Campylobacter pylori infection. Scand J Gastroenterol 1989; 24 (Supl 160): 19-24.
25. El-Zimaity HMT, Al-Assi MT, Genta RM, Graham DY. Confirmation of successful therapy of H. pylori infection: number and site of biopsies or a rapid urease test. Am J Gastroenterol 1995; 90: 1962-1964.
26. Gisbert JP, Boixeda D, Martin de Argila C, García Plaza A. La obtención de biopsias antrales es suficiente para confirmar la erradicación de Helicobacter pylori con las nuevas terapias triples de una semana de duración. Med Clin (Barc) 1999, 112: 365-367.
27. Guidelines for clinical trials in H. pylori infection. Technical annex: test used to assess H. pylori infection. Gut 1997; 41 (Supl 2): 10-18.
28. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Wokshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
29. Graham DY, Go MF. Evaluation of new antiinfective drugs for H. pylori infection: revised and updated. Clin Infect Dis 1993, 17: 293-294.
30. Xia HX, Talley NJ, Keane CT, O'Morain CA. Recurrence of H. pylori infection after successful eradication. Nature and possible causes. Dig Dis Sci 1997; 42: 1821-1834.
31. Tytgat GNJ. H. pylori: causal agent in peptic ulcer disease? J Gastroenterol Hepatol 1990; 5: 36-45.
32. Seppälä K, Färkkilä M, Nuutinen H, Hakala K, Vaananen H, Rautelin H et al. Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol 1992; 27: 973-976.
33. Wilde MI, McTavish D. Omeprazole. An update of its pharmacology ad therapeutic use in acid-related disorders. Drugs 1994; 48: 91-132.
34. Sasakii M, Joh T, Yokoyama Y, Seno K, Tsuchida K, Kurokawa T et al. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers. J Pharm Pharmacol 1999; 51: 825-830.
35. Van der Hulst RWM, Rauws EAJ, Köycü B, Keller JJ, Bruno JM, Tijssen JGP. Prevention of ulcer recurrence alter eradication of Helicobacter pylori: a prospective long-term follow up study. Gastroenterology 1997; 113: 1082-1086.
36. Bell GD, Powell KU. H. pylori reinfection after apparent eradication. The Ipswich experience. Scand J Gastroenterol 1996; 31 (Supl 215): 96-104.
37. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflamatory drugs. Lancet 1994; 343: 769-772.
38. Hallas J, Lauritsen J, Villadsen HD, Gram LF. Nonsteroidal antiinflammatory drugs and upper gastrointestinal bleeding: identifying high-risk group by excess risk estimates. Scand J Gastroenterol 1995; 30: 438-444.